Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,058
Closed -$373K 61
2023
Q4
$373K Hold
10,058
0.03% 57
2023
Q3
$365K Hold
10,058
0.03% 58
2023
Q2
$358K Hold
10,058
0.03% 60
2023
Q1
$358K Hold
10,058
0.03% 59
2022
Q4
$353K Hold
10,058
0.03% 61
2022
Q3
$296K Sell
10,058
-1
-0% -$38 0.03% 66
2022
Q2
$547K Hold
10,059
0.06% 51
2022
Q1
$548K Hold
10,059
0.05% 55
2021
Q4
$555K Hold
10,059
0.04% 60
2021
Q3
$480K Hold
10,059
0.03% 62
2021
Q2
$501K Hold
10,059
0.03% 58
2021
Q1
$449K Buy
+10,059
New +$457K 0.03% 60

Other funds holding GSK

First Light Asset Management's GSK Position: Q1 2024 in Review

First Light Asset Management sold out of GSK (GSK) in Q1 2024, closing a stake of 10,058 shares — an estimated $373K sold.

First Light Asset Management first reported a position in GSK in Q1 2021 and held it in 12 quarters. The position peaked at $555K in Q4 2021. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

  • First Light Asset Management reported no remaining GSK position as of Q1 2024 after selling out during the quarter.
  • First Light Asset Management sold 10,058 GSK shares in Q1 2024, an estimated $373K.
  • First Light Asset Management first reported a position in GSK in Q1 2021 and held it in 12 quarters.
  • First Light Asset Management's GSK position peaked at $555K in Q4 2021.
  • 910 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on First Light Asset Management's 13F filing for Q1 2024, filed 15 May 2024.